Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

The Lancet

Volumn 346, Issue 8982, 1995, Pages 1056-1059

  Feu, F ^a   García Pagán, J C ^a   Bosch, J ^a   Luca, A ^a   Escorsell, A ^a   Rodés, J ^a   Terés, J ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL;

ADULT; ARTICLE; CONTROLLED STUDY; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; SCLEROTHERAPY; VENOUS PRESSURE;

EID: 0028790232     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91740-3     Document Type: Article

References (32)

1. Clinical manifestations and management of bleeding episodes in cirrhotics
2. Natural history and prognosis of variceal bleeding
3. Definitions, methodology and therapeutic strategies in portal hypertension. A consensus development workshop
4. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis
5. Therapeutic controversies and randomised controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis
6. Meta-analysis of value of propranolol in prevention of variceal haemorrhage
7. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: a multicenter, randomized clinical trial
8. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials
9. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis
10. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis
11. Short term effects of propranolol on portal venous pressure
12. Double-blind investigation of the effects of propranolol and placebo on the pressure of the esophageal varices in patients with portal hypertension
13. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
14. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis
15. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis A randomized controlled trial
16. Radiographic application of receiver operating characteristic (ROC) curves
17. Prophylactic endoscopic sclerosing treatment of esophageal wall in varices. A prospective controlled randomized trial
18. Copenhagen Oesophageal Varices Sclerotherapy Project Sclerotherapy after first variceal hemorrhage in cirrhosis A randomized multicenter trial
19. A controlled trial of oral propranolol compared with injection Sclerotherapy for the long-term management of variceal bleeding
20. Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomised controlled trial
21. Endoscopic Sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices
22. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices
23. Portal hypertension in cirrhosis: natural history
24. A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation
25. A controlled study of the therapeutic portacaval shunt
26. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis
27. Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices
28. Sclerotherapy vs distal spleno-renal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial
29. Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial
30. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective randomized trial
31. Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. First stage of a randomized controlled trial
32. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis